‘Super Site’ Velocity Clinical Research Acquired by European Private Equity: Site Transformations Goes to the Next Level

‘Super Site’ Velocity Clinical Research Acquired by European Private Equity Site Transformations Goes to the Next Level

Rapid growth in any business certainly attracts positive attention and in the world of clinical research trial sites even more so as scale becomes ever so tricky with health care being such a fundamentally local affair. The integrated trial site operation, one that can maintain high quality, patient commitment and that local connection while simultaneously investing and growing a culture instituting scalable systems and processes—such as quality management and integrated trial management technologies to concerted business development—now led to the acquisition of Velocity Clinical Research. Founded just a few years ago with financial backing by NaviMed Capital, thanks to the leadership of President and CEO Dr. Paul Evans and team, this integrated trial site organization has executed what TrialSite considers a notable accomplishment, culminating in the acquisition of the entire company by Global Healthcare Opportunities (GHO), a Europe-based private equity house. The sale will close in Q2 2021, subject to regulatory approval. A wise, experienced, humble, and introspective Dr. Evans drove Velocity’s meteoric rise over just a couple years, leading to the accumulation of 16 trials sit...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee